The Israeli military has admitted that a Palestinian man with Down's syndrome who was attacked by an army dog in Gaza was left on his own by soldiers, after his family had been ordered to leave.

Phase 1/2 of the clinical trial shows that the administration of the AEF0217 molecule developed by the biotech Aelis Farma, is safe and can improve key skills such as communication, social ...